mTORC2 regulates non-homologous end joining through modulating the temporal dynamics of 53BP1.

IF 6.1 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS
Chunqing Wang, Hao Wang, Yunqiu Wang, Mingming Xiao, Xiaoxuan Song, Xiaofei Wang, Xiaofang Zhang, Kexing Jin, Dongqing Zhao, Hanxiang Chen, Ning Zhang, Ruibing Chen
{"title":"mTORC2 regulates non-homologous end joining through modulating the temporal dynamics of 53BP1.","authors":"Chunqing Wang, Hao Wang, Yunqiu Wang, Mingming Xiao, Xiaoxuan Song, Xiaofei Wang, Xiaofang Zhang, Kexing Jin, Dongqing Zhao, Hanxiang Chen, Ning Zhang, Ruibing Chen","doi":"10.1016/j.mcpro.2025.101035","DOIUrl":null,"url":null,"abstract":"<p><p>DNA damage repair is a critical biological process that maintains genomic integrity, and its dysregulation is closely related to tumorigenesis. To reveal the roles of mammalian target of rapamycin complex 2 (mTORC2) in DNA damage response (DDR), we investigated the temporal changes of cellular protein phosphorylation in mTORC2 deficient renal cancer cells in response to DNA double-strand break (DSB) induced by ionizing radiation (IR) using quantitative phosphoproteomics. The results showed that knockdown of Rictor, a specific component of mTORC2, induced profound changes in the dynamics of protein phosphorylation in response to IR. Intriguingly, the phosphorylation levels of multiple signaling molecules from the non-homologous end joining (NHEJ) pathway were affected by Rictor. Mechanistic study revealed that mTORC2 could regulate the spatiotemporal dynamics of p53 binding protein 1 (53BP1) in DDR. Rictor knockdown changed the phosphorylation of 53BP1 at multiple Ser/Thr sites. The efficiency of NHEJ was significantly reduced in Rictor deficient cells, and the maintenance of 53BP1 nuclear foci induced by IR was prolonged. Furthermore, mTORC2 modulated DSB repair through protein kinase B (PKB/Akt) and cyclin-dependent kinase 1 (CDK1). Finally, Rictor knockdown conferred hypersensitivity to IR and chemotherapeutic treatment in renal cancer cells, implying the potential use of the combination of mTORC2 inhibition with genotoxic therapy for renal cancer treatment.</p>","PeriodicalId":18712,"journal":{"name":"Molecular & Cellular Proteomics","volume":" ","pages":"101035"},"PeriodicalIF":6.1000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular & Cellular Proteomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.mcpro.2025.101035","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

DNA damage repair is a critical biological process that maintains genomic integrity, and its dysregulation is closely related to tumorigenesis. To reveal the roles of mammalian target of rapamycin complex 2 (mTORC2) in DNA damage response (DDR), we investigated the temporal changes of cellular protein phosphorylation in mTORC2 deficient renal cancer cells in response to DNA double-strand break (DSB) induced by ionizing radiation (IR) using quantitative phosphoproteomics. The results showed that knockdown of Rictor, a specific component of mTORC2, induced profound changes in the dynamics of protein phosphorylation in response to IR. Intriguingly, the phosphorylation levels of multiple signaling molecules from the non-homologous end joining (NHEJ) pathway were affected by Rictor. Mechanistic study revealed that mTORC2 could regulate the spatiotemporal dynamics of p53 binding protein 1 (53BP1) in DDR. Rictor knockdown changed the phosphorylation of 53BP1 at multiple Ser/Thr sites. The efficiency of NHEJ was significantly reduced in Rictor deficient cells, and the maintenance of 53BP1 nuclear foci induced by IR was prolonged. Furthermore, mTORC2 modulated DSB repair through protein kinase B (PKB/Akt) and cyclin-dependent kinase 1 (CDK1). Finally, Rictor knockdown conferred hypersensitivity to IR and chemotherapeutic treatment in renal cancer cells, implying the potential use of the combination of mTORC2 inhibition with genotoxic therapy for renal cancer treatment.

mTORC2通过调节53BP1的时间动态来调节非同源末端连接。
DNA损伤修复是维持基因组完整性的重要生物学过程,其失调与肿瘤发生密切相关。为了揭示哺乳动物雷帕霉素靶蛋白2 (mTORC2)在DNA损伤反应(DDR)中的作用,我们利用定量磷酸化蛋白质组学研究了mTORC2缺陷肾癌细胞在电离辐射(IR)诱导DNA双链断裂(DSB)时细胞蛋白磷酸化的时间变化。结果表明,敲低mTORC2的一个特定组分Rictor,会在响应IR时引起蛋白磷酸化动力学的深刻变化。有趣的是,来自非同源末端连接(NHEJ)途径的多个信号分子的磷酸化水平受到Rictor的影响。机制研究发现mTORC2可调控DDR中p53结合蛋白1 (53BP1)的时空动态。Rictor敲除改变了53BP1多个Ser/Thr位点的磷酸化。在Rictor缺陷细胞中,NHEJ的效率显著降低,IR诱导的53BP1核病灶维持时间延长。此外,mTORC2通过蛋白激酶B (PKB/Akt)和细胞周期蛋白依赖性激酶1 (CDK1)调节DSB修复。最后,Rictor敲低会导致肾癌细胞对IR和化疗产生超敏反应,这意味着mTORC2抑制与基因毒性治疗联合用于肾癌治疗的潜在应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular & Cellular Proteomics
Molecular & Cellular Proteomics 生物-生化研究方法
CiteScore
11.50
自引率
4.30%
发文量
131
审稿时长
84 days
期刊介绍: The mission of MCP is to foster the development and applications of proteomics in both basic and translational research. MCP will publish manuscripts that report significant new biological or clinical discoveries underpinned by proteomic observations across all kingdoms of life. Manuscripts must define the biological roles played by the proteins investigated or their mechanisms of action. The journal also emphasizes articles that describe innovative new computational methods and technological advancements that will enable future discoveries. Manuscripts describing such approaches do not have to include a solution to a biological problem, but must demonstrate that the technology works as described, is reproducible and is appropriate to uncover yet unknown protein/proteome function or properties using relevant model systems or publicly available data. Scope: -Fundamental studies in biology, including integrative "omics" studies, that provide mechanistic insights -Novel experimental and computational technologies -Proteogenomic data integration and analysis that enable greater understanding of physiology and disease processes -Pathway and network analyses of signaling that focus on the roles of post-translational modifications -Studies of proteome dynamics and quality controls, and their roles in disease -Studies of evolutionary processes effecting proteome dynamics, quality and regulation -Chemical proteomics, including mechanisms of drug action -Proteomics of the immune system and antigen presentation/recognition -Microbiome proteomics, host-microbe and host-pathogen interactions, and their roles in health and disease -Clinical and translational studies of human diseases -Metabolomics to understand functional connections between genes, proteins and phenotypes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信